D-glucosamine sulfate 2KCl
Glucosamine Sulfate (2KCl) · also known as Glucosamine sulfate, Glucosamine sulfate, Glucosamine, Glucosamine
Glucosamine sulfate is a building block for glycosaminoglycan synthesis in cartilage. It can be detected in joint synovial fluid after oral intake, but whether it promotes matrix repair in human cartilage has not been directly confirmed, and clinical effects vary by salt form and product.
Clinical uses and human evidence
Osteoarthritis pain
Studies (3)
- Wangroongsub 2010 · J Med Assoc Thai · RCT · n=90 — Comparable clinical outcomes between glucosamine sulfate-potassium chloride and glucosamine sulfate sodium chloride in patients with mild and moderate knee osteoarthritis: a randomized, double-blind study
- Herrero-Beaumont 2007 · Arthritis Rheum · RCT · n=318 — Glucosamine sulfate in the treatment of knee osteoarthritis symptoms: a randomized, double-blind, placebo-controlled study using acetaminophen as a side comparator
- Hughes 2002 · Rheumatology (Oxford) · RCT · n=80 — A randomized, double-blind, placebo-controlled trial of glucosamine sulphate as an analgesic in osteoarthritis of the knee
All-cause mortality risk
Studies (3)
- Yan 2026 · J Cancer · Meta-analysis — Glucosamine Use and Its Association with Colorectal Cancer and Mortality: A Systematic Review and Meta-Analysis
- Li 2020 · Ann Rheum Dis · Cohort study · n=495077 — Associations of regular glucosamine use with all-cause and cause-specific mortality: a large prospective cohort study
- Bhimani 2023 · J Integr Complement Med · Cohort study · n=38021 — Glucosamine and Chondroitin Use and Mortality Among Adults in the United States from 1999 to 2014
Heart attack, stroke and other cardiovascular events
Studies (2)
- Ma 2019 · BMJ · Cohort study · n=466039 — Association of habitual glucosamine use with risk of cardiovascular disease: prospective study in UK Biobank
- Bhimani 2023 · J Integr Complement Med · Cohort study · n=38021 — Glucosamine and Chondroitin Use and Mortality Among Adults in the United States from 1999 to 2014
Falls in older adults
Mechanisms of action
Joint cartilage matrix glycan (GAGs/Aggrecan) repair and lubrication
In an isotope-tracing study in dogs, orally administered labeled glucosamine entered articular cartilage and was used by chondrocytes. In a human pharmacokinetic study, the median glucosamine concentration in synovial fluid after a routine dose was about 4.34 μM. This does not yet show that routine doses significantly promote matrix repair in human cartilage.
Inhibition of NF-κB / AP-1, the master switches of pro-inflammatory transcription
In a mouse dietary study, glucosamine sulfate reduced NF-κB-related expression in a colitis model. The findings on inhibiting nuclear translocation of NF-κB p65 in chondrocytes come mainly from experimental models and have not been confirmed in human joints at usual oral doses.
Safety and drug interactions
Additive bleeding risk
Reports of raised INR when taken with warfarin. Each of these has a mild antiplatelet or fibrinolytic effect. Alone, the effect is usually small, but when several are combined, the tendency to bleed becomes more noticeable. Stop them 1–2 weeks before surgery or a tooth extraction, and watch for gum bleeding or more bruising.
With Anticoagulants Needs attention
There are reports of raised INR, and even serious bleeding, when glucosamine was started or the dose increased during warfarin therapy. How often this happens is unknown. People taking warfarin should have an extra INR check after starting, stopping or changing the dose of glucosamine (warfarin only).